Beta-blockers do not impair the cardiovascular benefits of endurance training in hypertensives

Journal of Human Hypertension

Volumn 21, Issue 6, 2007, Pages 486-493

  Westhoff, T H ^a   Franke, N ^a   Schmidt, S ^a   Vallbracht Israng, K ^a   Zidek, W ^a   Dimeo, F ^a   van der Giet, M ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CALCIUM CHANNEL BLOCKING AGENT; CARVEDILOL; CLONIDINE; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; LACTIC ACID; METOPROLOL; NEBIVOLOL; VERAPAMIL;

ADULT; AEROBIC EXERCISE; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; BLOOD PRESSURE MONITORING; CARDIOVASCULAR EFFECT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ENDURANCE; EXERCISE; FEMALE; GERIATRIC PATIENT; HEART RATE; HUMAN; HYPERTENSION; LACTATE BLOOD LEVEL; MALE; PHYSICAL ACTIVITY; PHYSICAL PERFORMANCE; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; TREADMILL EXERCISE; VASCULAR ENDOTHELIUM; VASODILATATION;

ADRENERGIC BETA-ANTAGONISTS; AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; ENDOTHELIAL CELLS; EXERTION; FEMALE; HEART; HEART RATE; HUMANS; HYPERTENSION; MALE; PHYSICAL ENDURANCE; VASODILATION;

EID: 34249311970     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/sj.jhh.1002173     Document Type: Article

References (29)

1. 2003 European Society of Hypertension-European Society of Cardiology. Guidelines for the management of arterial hypertension. J Hypertens 2003; 21: 1011-1053.
2. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo Jr JL et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289: 2560-2572.
3. Cornelissen VA, Fagard RH. Effects of endurance training on blood pressure, blood pressure-regulating mechanisms, and cardiovascular risk factors. Hypertension 2005; 46: 667-675.
4. Maiorana A, O'Driscoll G, Taylor R, Green D. Exercise and the nitric oxide vasodilator system. Sports Med 2003; 33: 1013-1035.
5. Jennings GL. Exercise and blood pressure: Walk, run or swim? J Hypertens 1997; 15: 567-569.
6. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo Jr JL et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206-1252.
7. Thiele H, Pohlink C, Schuler G. Hypertension and exercise. Sports methods for the hypertensive patient. Herz 2004; 29: 401-405.
8. Hagberg JM, Park JJ, Brown MD. The role of exercise training in the treatment of hypertension: An update. Sports Med 2000; 30: 193-206.
9. Whelton SP, Chin A, Xin X, He J. Effect of aerobic exercise on blood pressure: A meta-analysis of randomized, controlled trials. Ann Intern Med 2002; 136: 493-503.
10. Beaver WL, Wasserman K, Whipp BJ. A new method for detecting anaerobic threshold by gas exchange. J Appl Physiol 1986; 60: 2020-2027.
11. Kindermann W, Simon G, Keul J. The significance of the aerobic-anaerobic transition for the determination of work load intensities during endurance training. Eur J Appl Physiol Occup Physiol 1979; 42 25-34.
12. Medicine ACoS. ACSM's guidelines for exercise testing and prescription. Lippincott Williams & Wilkins: Philadelphia, PA, 2000 pp 145-199.
13. Fletcher GF, Balady GJ, Amsterdam EA, Chaitman B, Eckel R, Fleg J et al. Exercise standards for testing and training: A statement for healthcare professionals from the American Heart Association. Circulation 2001; 104: 1694-1740.
14. Ketelhut RG. Endurance training in hypertension is effective. Which form of sports, frequency and intensity of training? When should adjuvant chemotherapy be considered? Fortschr Med 1998; 116: 26-28 30-22.
15. Savin WM, Gordon EP, Kaplan SM, Hewitt BF, Harrison DC, Haskell WL. Exercise training during long-term beta-blockade treatment in healthy subjects. Am J Cardiol 1985; 55: 101D-109D.
16. Howlett KF, Watt MJ, Hargreaves M, Febbraio MA. Regulation of glucose kinetics during intense exercise in humans: Effects of alpha- and beta-adrenergic blockade. Metabolism 2003; 52: 1615-1620.
17. Hambrecht RP, Niebauer J, Fiehn E, Marburger CT, Muth T, Offner B et al. Effect of an acute beta-adrenergic blockade on the relationship between ventilatory and plasma lactate threshold. Int J Sports Med 1995; 16: 219-224.
18. Wonisch M, Hofmann P, Fruhwald FM, Kraxner W, Hodl R, Pokan R et al. Influence of beta-blocker use on percentage of target heart rate exercise prescription. Eur J Cardiovasc Prev Rehabil 2003; 10 296-301.
19. American College of Sports Medicine, Preventive and Rehabilitative Exercise Committee. Guidelines for Exercise Testing and Prescription 5th ed. Lea & Feibiger: Philadelphia, PA, 1995.
20. Dimeo FC, Tilmann MH, Bertz H, Kanz L, Mertelsmann R, Keul J. Aerobic exercise in the rehabilitation of cancer patients after high dose chemotherapy and autologous peripheral stem cell transplantation. Cancer 1997; 79: 1717-1722.
21. Vallbracht KB, Schwimmbeck PL, Seeberg B, Kuhl U, Schultheiss HP. Endothelial dysfunction of peripheral arteries in patients with immunohistologically confirmed myocardial inflammation correlates with endothelial expression of human leukocyte antigens and adhesion molecules in myocardial biopsies. J Am Coll Cardiol 2002; 40 515-520.
22. Vallbracht KB, Schwimmbeck PL, Kuhl U, Seeberg B, Schultheiss HP. Endothelium-dependent flow-mediated vasodilation of systemic arteries is impaired in patients with myocardial virus persistence. Circulation 2004; 110: 2938-2945.
23. Pyke KE, Tschakovsky ME. The relationship between shear stress and flow-mediated dilatation: Implications for the assessment of endothelial function. J Physiol 2005; 568: 357-369.
24. Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992; 340: 1111-1115.
25. Sorensen KE, Celermajer DS, Spiegelhalter DJ, Georgakopoulos D, Robinson J, Thomas O et al. Non-invasive measurement of human endothelium dependent arterial responses: Accuracy and reproducibility. Br Heart J 1995; 74: 247-253.
26. Pescatello LS, Franklin BA, Fagard R, Farquhar WB, Kelley GA, Ray GA. American College of Sports Medicine position stand. Exercise and hypertension. Med Sci Sports Exerc 2004; 36: 533-553.
27. Pokan R, Huonker M, Lehmann M, Dickhuth HH, Keul J. Effect of beta blockade on hemodynamics in physical exertion. Wien Med Wochenschr 1990; 140: 178-184.
28. Van Baak MA. Beta-adrenoceptor blockade and exercise. An update. Sports Med 1988; 5: 209-225.
29. Wilkinson IB, Hall IR, MacCallum H, Mackenzie IS, McEniery CM, van der Arend BJ et al. Pulse-wave analysis: Clinical evaluation of a noninvasive, widely applicable method for assessing endothelial function. Arterioscler Thromb Vasc Biol 2002; 22: 147-152.